CRISPR hits a snag: Our immune systems may attack the treatment
Posted: January 11, 2018 at 5:42 am
A
new paper points to a previously unknown hurdle for scientists racing to develop therapies using the revolutionary genome-editing tool CRISPR-Cas9: the human immune system.
In a study posted Friday on the preprint site bioRxiv, researchers reported that many people have existing immune proteins and cells primed to target the Cas9 proteins included in CRISPR complexes. That means those patients might be immune to CRISPR-based therapies or vulnerable to dangerous side effects the latter being especially concerning as CRISPR treatments move closer to clinical trials.
But researchers not involved with the study said its findings, if substantiated, could be worked around. (Papers are posted to bioRxiv before being peer-reviewed.) Many of the first planned CRISPR clinical trials, for example, involve removing cells from patients, fixing their DNA, and then returning them to patients. In that case, its possible that there will be few or no CRISPR proteins remaining for the immune system to detect.
advertisement
They also noted that scientists are already studying other types of CRISPR that use different proteins, which could stave off the immune responses.
At the end of the day, Im not that concerned about it, said Daniel Anderson of the Massachusetts Institute of Technology, who has studied the delivery of CRISPR therapies and who was not involved with the new study. But we want to do some experiments to learn more.
The new study should not put the brakes on developing CRISPR therapies, agreed Dr. Matthew Porteus of Stanford, a senior author of the paper and who is himself at work on a CRISPR-based therapy for sickle cell disease. But he said he and his colleagues investigated the immune issues because he felt they were being overlooked as the excitement around CRISPR grew.
Like any new technology, you want to identify potential problems and engineer solutions for them, Porteus said. And I think thats where were at. This is an issue that should be addressed.
(Porteus and Anderson are both scientific founders of CRISPR Therapeutics, one of the most prominent companies exploring CRISPR-based therapies.)
CRISPR has gained fame in recent years as researchers have deployed it to correct an array of disease-causing mutations in cells in the lab and in animal models, with hopes that the same results can be achieved in people. There are different types of CRISPR systems, but the most well known is dubbed CRISPR-Cas9; it includes Cas9 proteins that cut DNA so that it can be edited. Cas9 proteins come from bacteria.
For the study, the researchers decided to check for immune signals against two of the most common types of Cas9 proteins used, those from the bacteria S. aureus (called SaCas9) and those from S. pyogenes (called SpCas9). In their samples of blood from 22 newborns and 12 adults, the scientists found that 79 percent of donors had immune proteins, called antibodies, against SaCas9, and 65 percent had antibodies against SpCas9.
The researchers then searched for immune cells called T cells. They discovered that about half of the donors had T cells that specifically targeted SaCas9, so that if the immune cells detected that protein on the surface of a cell, they would rally a response to try to destroy it. The researchers did not find anti-SpCas9 T cells, though they said the cells might still have been present.
Its not surprising so many of the donors had antibodies and T cells against the Cas9 proteins, experts said. That simply means that those people had been exposed to the bacteria containing the proteins in the past, and other studies have found that, at any given time, 40 percent of people are colonized by S. aureus and 20 percent of schoolchildren have S. pyogenes. The bacteria only sometimes cause disease.
But what then does that previous exposure mean for our receptiveness to CRISPR therapies?
A lot remains unclear, Porteus said. Its not known how severe the immune response would be, and whether it would trigger a dangerous inflammatory attack or just render the treatment useless.
Experts also said that perhaps the immune responses could be avoided. If the CRISPR complex does its editing after the cells are removed from the patient whats called ex vivo or in a place like the eye that is isolated from the immune system, then the antibodies and T cells might not detect any Cas9 proteins. Even in in vivo therapies in which CRISPR complexes would be ferried into cells in a patients body much depends on what kind of delivery system is used and whether the Cas9 proteins become expressed on the outside of the cells in which the editing is taking place.
Porteus said he and his team decided to post the paper on bioRxiv because they wanted CRISPR researchers to start thinking now about possible immune system challenges. The team has also submitted the paper to a journal for peer review and publication.
As a cautionary tale about the importance of asking these questions now, Porteus pointed to what happened with gene therapy in 1999. In that case, a patient in a trial died after an immune system attack, likely because he had preexisting antibodies against a virus used as part of the therapy. The death led to years lost in gene therapy development, experts say. (Patients who have preexisting antibodies to viruses used in gene therapies are now generally excluded from trials.)
I would hate to see the field have a major setback because we didnt address this potential issue, Porteus said. We should learn from that.
Roland Herzog, a gene therapy expert at the University of Florida, agreed that the hype around CRISPR meant that possible immune issues were not being given enough credence.
I suspect that the field has not been aware of it sufficiently, he said. Its not a show stopper, he added about the paper, but the field needs to know about this, that its a potential problem that they need to work around or fix.
One possible fix is simply using a different protein or enzyme in the CRISPR complex, one that doesnt come from such common bacteria. If people havent been exposed to the bacterial protein previously, then they wont have specific antibodies or T cells ready to attack.
New Cas editing enzymes are being described all the time from bacterial species that are not human pathogens (and so there would be no chance to develop the pre-existing antibodies), Jacob Corn, of the University of California, Berkeley, who was not involved with the new paper, wrote in an email. I also know some people have already been working on making Cas enzymes that would be invisible to the immune system.
He added: The field moves very fast!
General Assignment Reporter
Andrew is a general assignment reporter at STAT.
Go here to see the original:
CRISPR hits a snag: Our immune systems may attack the treatment
- Antibodies Part 1: CRISPR - Radiolab - March 20th, 2018
- Crispr gene editing ready for testing in humans - ft.com - March 7th, 2018
- CRISPR - YouTube - March 6th, 2018
- Researchers advance CRISPR-based tool for diagnosing disease ... - February 17th, 2018
- Researchers use CRISPR to detect HPV and Zika - February 16th, 2018
- CRISPR Gene Editing And 3 Biotech Companies Blaze New Path To ... - February 7th, 2018
- Chinese scientists already used Crispr gene editing on 86 ... - January 29th, 2018
- Crisprs Next Big Challenge: Getting Where It Needs to Go | WIRED - January 26th, 2018
- New CRISPR method could take gene editing to the next level - January 20th, 2018
- Obstacle to Using CRISPR in Humans? The Immune System - The ... - January 11th, 2018
- In 2018, We Will CRISPR Human Beings - gizmodo.com - December 28th, 2017
- Crispr Isnt Enough Any More. Get Ready for Gene Editing 2.0 - December 27th, 2017
- With CRISPR, geneticists have a powerful new weapon in the ... - December 27th, 2017
- CRISPR gene editing is coming to the clinic | Chemical ... - December 18th, 2017
- CRISPR Timeline CRISPR Update - December 17th, 2017
- CRISPR breakthrough treats diseases like diabetes without ... - December 12th, 2017
- The best and worst analogies for CRISPR, ranked - December 10th, 2017
- How Does Crispr Gene Editing Work? | WIRED - December 6th, 2017
- CRISPR: can gene-editing help nature cope with climate change? - November 30th, 2017
- What are genome editing and CRISPR-Cas9? - November 27th, 2017
- CRISPR - youtube.com - November 21st, 2017
- CRISPR gene editing gets new tools, and acronyms - October 30th, 2017
- Amid GMO Strife, Food Industry Vies For Public Trust In ... - October 25th, 2017
- The Latest Guide to Understanding CRISPR-Cas9 - October 25th, 2017
- CRISPR toolbox gets two new molecular gadgets, boosting gene ... - October 25th, 2017
- CRISPR Bacon: Chinese Scientists Create Genetically Modified ... - October 25th, 2017
- Gene-editing tool CRISPR can now manipulate more types of ... - October 25th, 2017
- How CRISPR gene-editing tech can fight HIV - SFGate - October 23rd, 2017
- Video stored in live bacterial genome using CRISPR gene ... - October 23rd, 2017
- Everything You Need to Know About CRISPR, the New Tool that ... - October 16th, 2017
- CRISPR Gene Editing and the DNA of Future Food | Digital Trends - October 14th, 2017
- Scientists successfully used CRISPR to fix a mutation that ... - October 14th, 2017
- CRISPR Update CRISPR Updates, News and Articles - October 2nd, 2017
- CRISPR breakthrough could drop miscarriage rates | TechCrunch - September 28th, 2017
- CRISPR gene-editing could result in more successful birth rates - September 27th, 2017
- CRISPR: A game-changing genetic engineering technique ... - September 24th, 2017
- Thanks to CRISPR, gene-edited pigs could be organ donors for ... - September 24th, 2017
- Birth of CRISPR'd pigs advances hopes for turning pigs into ... - September 24th, 2017
- CRISPR - CRISPR-Cas9 | Gene Editing - September 24th, 2017
- Artis funds Excision to test whether CRISPR can cure HIV ... - FierceBiotech - September 7th, 2017
- New gene editing tech promises to be even better than CRISPR - Digital Trends - September 7th, 2017
- Eterna Citizen Science Game Turns Its Attention To CRISPR - HuffPost - September 6th, 2017
- Scientists use CRISPR technology to change flower colour - Phys.org - Phys.Org - September 6th, 2017
- Workshop Next Week On Public Interest And CRISPR Gene Editing, CAR T Cancer Treatment - Intellectual Property Watch - September 4th, 2017
- A Fourth-Generation DNA Base Editor Could Replace CRISPR - Futurism - September 4th, 2017
- Skepticism surfaces over CRISPR human embryo editing claims ... - Science Magazine - September 3rd, 2017
- Scientists Upload a Galloping Horse GIF Into Bacteria With ... - September 3rd, 2017
- 'Gentler' CRISPR sheds light on autoimmune disease | FierceBiotech - FierceBiotech - September 3rd, 2017
- Video gamers tasked with helping develop new molecule for controlling CRISPR - New Atlas - September 3rd, 2017
- We're Failing Our Test Run for the Age of CRISPR | The Nation - The Nation. - August 30th, 2017
- Online game challenges players to design on/off switch for CRISPR ... - Stanford Medical Center Report - August 30th, 2017
- CRISPR gene editing eliminates HIV infection in mice ... - August 28th, 2017
- CRISPR-Cas9 corrects hypertrophic cardiomyopathy gene mutation in human preimplantation embryos [PreClinical] - 2 Minute Medicine - August 28th, 2017
- Five myths about gene editing - The Washington Post - Washington Post - August 25th, 2017
- CRISPR May One Day Cure Sickle-Cell Disease - Futurism - August 25th, 2017
- Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass General - Endpoints News - August 25th, 2017
- CRISPR Therapeutics Joins Hospital For Cancer Treatment Tests - Futurism - August 24th, 2017
- Boom in human gene editing as 20 CRISPR trials gear up | New ... - August 24th, 2017
- Will CRISPR fears fade with familiarity? - The Conversation US - August 24th, 2017
- CRISPR, Patents, and Nobel Prizes - lareviewofbooks - August 24th, 2017
- CRISPR Therapeutics, MGH Partner to Develop T-Cell Cancer Therapies - Genetic Engineering & Biotechnology News - August 24th, 2017
- Crispr Fans Dream of a Populist Future for Gene Editing | WIRED - WIRED - August 20th, 2017
- CRISPR Co-Discoverer: "I've Never Seen Science Move at the Pace ... - Futurism - August 20th, 2017
- Genome editing CRISPR technique takes center stage | Feedstuffs - Feedstuffs - August 20th, 2017
- CRISPR and the Ethics of Human Embryo Research - Foreign Affairs - August 20th, 2017
- Monsanto adds another CRISPR platform to genetic toolbox - Farm ... - Farm and Dairy - August 20th, 2017
- Scientists Use CRISPR Gene Editing to Create the World's First ... - Big Think - August 14th, 2017
- Pig-to-Human Transplants: CRISPR Gene Editing May Make This Possible - Live Science - August 14th, 2017
- CRISPR'd pigs offer hope for the human organ transplant shortage - TechCrunch - August 11th, 2017
- Researchers use CRISPR to manipulate social behavior in ants - Phys.Org - August 11th, 2017
- Researchers Used CRISPR to Manipulate the Social Activities of Ants - Futurism - August 11th, 2017
- CRISPR Therapeutics Announces Second Quarter 2017 Financial Results and Provides Business Update - GlobeNewswire (press release) - August 10th, 2017
- Gene Editing Might Mean My Brother Would've Never Existed - TIME - August 10th, 2017
- Mice made with CRISPR usher in new era of autism research - Spectrum - August 9th, 2017
- 11 Amazing Feats the Gene-Editing Tool CRISPR Just Made Possible - NBCNews.com - August 9th, 2017
- MilliporeSigma to Be Granted European Patent for CRISPR Technology - Genetic Engineering & Biotechnology News - August 8th, 2017
- 11 Incredible Things CRISPR Has Helped Us Achieve in 2017 - Futurism - August 8th, 2017
- CRISPR Skin Grafts Could Replace Insulin Shots For Diabetes - Futurism - August 8th, 2017
- CRISPR Screen Identifies Top 100 Essential Genes for Cancer ... - Genetic Engineering & Biotechnology News - August 8th, 2017
- CRISPR patent battle in Europe takes a 'wild' twist with surprising player - Science Magazine - August 5th, 2017